About Deinde Medical
Deinde Medical is a private company based in Miramar, Florida. It has reported $6,454,944 raised in four offerings on Form D since November 2019. Its chief executive is Marc Litzenberg.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 27, 2025 | Nov 12, 2025 | $185,000of $2.0M target | 3 | $61,667 | OptionsRule 506(b) | Form D ↗ |
| Oct 31, 2023 | Nov 9, 2023amended Feb 11, 2025 | $1,055,000of $2.0M target | 14 | $75,357 | Debt, OptionsRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 1, 2021 | Oct 15, 2021 | $2,533,285of $2.6M target | 35 | $72,380 | Debt, OptionsRule 506(b) | Form D ↗ |
| Nov 15, 2019 | Nov 27, 2019 | $2,681,659of $3.0M target | 29 | $92,471 | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $6,454,944 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Deinde Medical's Form D filed Nov 12, 2025.
BN
PL
Ajay Wakhloo
Director
Also a chief executive officer and director at NeuroFine and CEO and director at Prometheus Therapeutics.
ML
Marc Litzenberg
Chief Executive Officer and director
Also a director at NeuroFine and an executive officer and director at Prometheus Therapeutics.
JM
Earlier filings also listed Bernardo Navarro (executive officer, last listed Nov 2019).